A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia
Status:
Completed
Trial end date:
2020-11-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of administering a
single intravenous (IV) infusion dose of TAK-925 to adult participants with idiopathic
hypersomnia (IH).